Dark

NBIX
Neurocrine Biosciences Inc
stock NASDAQ

Market Open

Feb 5, 2026 10:18:15 AM EST

140.75USD+2.096%(+2.89)141,601

140.87Bid 141.14Ask 0.27Spread

Pre-market

0.00USD-100.000%(-137.86)0

After-hours

Feb 4, 2026 4:22:30 PM EST

137.86USD-0.011%(-0.01)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

14.03B

CEO

Kevin Gorman

Headquarters

San Diego, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Feb 11, 2026 (6d)

RGEN ATHX LLY PFE PTN ABBV ANIP CASI PRTK XLV

NBIX Stats

Avg. Vol. 10 Day

923,913

Avg. Vol. 30 Day

1,002,783

Employees

470

Market Cap

14,030,805,175

Shares Out.

99,705,698

On/Off Exchange

64%/36%

6 Month Beta

0.61

1 Year Beta

0.82

2 Year Beta

0.74

3 Year Beta

0.68

52 Week Low

84.23

52 Week High

160.18

SMA50

142.81

SMA200

134.58

1 Week

+2.00%

1 Month

+3.48%

3 Month

-8.47%

6 Month

+9.61%

1 Year

-6.93%

2 Year

-0.66%

5 Year

+21.17%

Profile

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

NBIX Stock Summary

Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $140.75, and today's volume is 141,601. NBIX is up 2.096% today. The 30 day average volume is 1,002,783. NBIX market cap is 14.03B with 99,705,698 shares outstanding.